Abstract: A method is provided for reverse transcription-polymerase chain reaction (RT-PCR) accomplished by: a) amplifying a reverse transcribed cDNA in a mixture containing Norovirus Genogroup I and Norovirus Genogroup II primers and probes, in which the Norovirus primers and probes can distinguish between Genogroup I and Genogroup II viruses; b) quantifying virus; and c) normalizing data based on a universal internal RNA control. Optionally, the method may also include primers and probes for Enteroviruses. The present invention also provides a reaction mixture containing Norovirus Genogroup I and Norovirus Genogroup II primers and probes, in which the Norovirus primers and probes can distinguish between Genogroup I and Genogroup II viruses and universal internal RNA control primers and probes.
Type:
Grant
Filed:
October 1, 2007
Date of Patent:
November 5, 2013
Assignee:
The United States of America as represented by the Department Secretary of Health and Human Services
Inventors:
William Burkhardt, III, Michael C. L. Vickery, Jessica Nordstrom
Abstract: Human nm23 DNA and protein is disclosed as well as antibodies which recognize human nm23 protein. The DNA and antibodies may be used to detect nm23 in human tumors to predict the malignancy potential of such tumors.
Type:
Grant
Filed:
June 18, 1999
Date of Patent:
December 11, 2001
Assignee:
The United States of America as represented by the Department
of Secretary Health & Human Services
Inventors:
Charles Richter King, Patricia Schriver Steeg, Lance A. Liotta